These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8240924)

  • 1. Rac-flurbiprofen is more ulcerogenic than its (S)-enantiomer.
    Wechter WJ; Bigornia AE; Murray ED; Levine BH; Young JW
    Chirality; 1993; 5(7):492-4. PubMed ID: 8240924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of enhancement of intestinal ulcerogenicity of S-aryl propionic acids by their R-enantiomers in the rat.
    Wechter WJ; McCracken JD; Kantoci D; Murray ED; Quiggle D; Leipold D; Gibson K; Mineyama Y; Liu Y
    Dig Dis Sci; 1998 Jun; 43(6):1264-74. PubMed ID: 9635617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics and pharmacokinetics of the profens: enantioselectivity, clinical implications, and special reference to S(+)-ibuprofen.
    Evans AM
    J Clin Pharmacol; 1996 Dec; 36(12 Suppl):7S-15S. PubMed ID: 9013378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the enantiomers of flurbiprofen, ibuprofen, and ketoprofen on intestinal permeability.
    Davies NM; Wright MR; Russell AS; Jamali F
    J Pharm Sci; 1996 Nov; 85(11):1170-3. PubMed ID: 8923320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.
    Radwan MA; Aboul-Enein HY
    Chirality; 2004 Feb; 16(2):119-25. PubMed ID: 14712475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer.
    Wechter WJ; Kantoci D; Murray ED; Quiggle DD; Leipold DD; Gibson KM; McCracken JD
    Cancer Res; 1997 Oct; 57(19):4316-24. PubMed ID: 9331093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of acute flurbiprofen and ketoprofen toxicity in rat gastric mucosa at therapy-relevant doses.
    Holzer P; Jocic M; Cabré F; Mauléon D
    Inflamm Res; 2001 Dec; 50(12):602-8. PubMed ID: 11822786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal ulcerogenic effect of S(+)-ketoprofen in the rat.
    Cabré F; Fernández F; Zapatero MI; Araño A; García ML; Mauleón D
    J Clin Pharmacol; 1998 Dec; 38(S1):27S-32S. PubMed ID: 9882079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R- and S-isomers of nonsteroidal anti-inflammatory drugs differentially regulate cytokine production.
    Mascagni P; Sabbatini V; Biordi L; Martinotti S; Allegretti M; Marullo A; Caselli G; Bertini R
    Eur Cytokine Netw; 2000 Jun; 11(2):185-92. PubMed ID: 10903797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical and clinical development of dexketoprofen.
    Mauleón D; Artigas R; García ML; Carganico G
    Drugs; 1996; 52 Suppl 5():24-45; discussion 45-6. PubMed ID: 8922555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R-flurbiprofen: isomeric ballast or active entity of the racemic compound?
    Geisslinger G; Menzel-Soglowek S; Beck WS; Brune K
    Agents Actions Suppl; 1993; 44():31-6. PubMed ID: 8372732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective inhibition of rat brain cyclooxygenase by dexketoprofen.
    Carabaza A; Cabré F; García AM; Rotllan E; García ML; Mauleón D
    Chirality; 1997; 9(3):281-5. PubMed ID: 9176993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and synovial fluid concentrations of flurbiprofen enantiomers in horses: chiral inversion.
    Soraci AL; Tapia O; Garcia J
    J Vet Pharmacol Ther; 2005 Feb; 28(1):65-70. PubMed ID: 15720517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chiral pharmacokinetics of Rac-flurbiprofen and pharmacodynamics of anabolic bone response in the normal rat.
    Wechter WJ; Bigornia AE; Murray ED; Jee WS
    Chirality; 1994; 6(6):457-9. PubMed ID: 7946972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the enantiomers of ibuprofen and flurbiprofen on the beta-oxidation of palmitate in the rat.
    Zhao B; Geisslinger G; Hall I; Day RO; Williams KM
    Chirality; 1992; 4(3):137-41. PubMed ID: 1586584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pure enantiomers of flurbiprofen in comparison to racemic flurbiprofen on eicosanoid release from various rat organs ex vivo.
    Peskar BM; Kluge S; Peskar BA; Soglowek SM; Brune K
    Prostaglandins; 1991 Dec; 42(6):515-31. PubMed ID: 1801061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of flurbiprofen, ketoprofen and etodolac enantiomers by pre-column derivatization RP-HPLC and application to drug-protein binding in human plasma.
    Jin YX; Tang YH; Zeng S
    J Pharm Biomed Anal; 2008 Apr; 46(5):953-8. PubMed ID: 18329215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselectivity of biliary excretion of 2-arylpropionates in rats.
    Menzel S; Beck WS; Brune K; Geisslinger G
    Chirality; 1993; 5(6):422-7. PubMed ID: 8398601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S- but not R-enantiomers of flurbiprofen and ibuprofen reduce human microglial and THP-1 cell neurotoxicity.
    Klegeris A; Maguire J; McGeer PL
    J Neuroimmunol; 2004 Jul; 152(1-2):73-7. PubMed ID: 15223239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease.
    Geerts H
    IDrugs; 2007 Feb; 10(2):121-33. PubMed ID: 17285465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.